GlassScriptPhysician profile
Jariatul Karim
NPI 1306973482
$415.20
in general payments reported to CMS, 2019-2025
11 companies · $53.35 in 2025
The $53.35 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.07 · 2021: $139 · 2022: $86.20 · 2023: $54.50 · 2024: $33.06 · 2025: $53.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.62 · Education: $54.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.62 |
| Education | $54.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $128.90 | 2020-2022 | |
| Glaxosmithkline, LLC. | $56.85 | 2021-2023 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $46.40 | 2020-2023 | Farxiga |
| Travere Therapeutics, INC. | $35.44 | 2024-2025 | Filspari |
| Amgen INC. | $32.12 | 2024-2025 | Tavneos |
| Fresenius USA Marketing, INC. | $22.04 | 2023 | Velphoro |
| Bayer Healthcare Pharmaceuticals INC. | $19.99 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Mallinckrodt Hospital Products INC. | $18.25 | 2022 | |
| Amarin Pharma, INC. | $16.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jariatul Karim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.